Voyager Therapeutics' IPO

Voyager Therapeutics raised a round of funding on November 11, 2015. Investors include Public.

Voyager Therapeutics is a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (CNS). Voyager is committed to advancing the field …

Articles about Voyager Therapeutics' IPO: